Breast Implant Revision
0
Pipeline Programs
1
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
BellaSenoGermany - Leipzig
3 programsImplantation of the PCL Breast scaffold with autologous fat graftingN/A1 trial
LTFU of PCL Breast Scaffolds Used in 2021-BRV-004N/A1 trial
Surgical implantation of the PCL Breast scaffold with autologous fat graftingN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
BellaSenoImplantation of the PCL Breast scaffold with autologous fat grafting
BellaSenoLTFU of PCL Breast Scaffolds Used in 2021-BRV-004
BellaSenoSurgical implantation of the PCL Breast scaffold with autologous fat grafting
Clinical Trials (3)
Total enrollment: 111 patients across 3 trials
Scaffold-guided Breast Implant Revision Surgery
Start: Feb 2026Est. completion: Jan 203273 patients
N/ARecruiting
LTFU of PCL Breast Scaffolds Used in 2021-BRV-004
Start: Feb 2026Est. completion: Feb 202919 patients
N/ANot Yet Recruiting
Scaffold-guided Breast Surgery
Start: Jun 2022Est. completion: Dec 202519 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 111 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.